Skip to content
RedDress Ltd. logo — Healing is in Our Blood

RedDress Ltd.

Healing is in Our Blood

Founded 2009 United States United States 40 employees Series D Total: $26.00M Biotechnology, Health Care +1

General Information

Company Name RedDress Ltd.
Founded Year 2009
Location United States United States
Employees 40
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with RedDress Ltd.. To contact RedDress Ltd., visit reddressmedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RedDress Ltd. compare?

A PDF of RedDress Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RedDress Ltd. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About RedDress Ltd.

RedDress Ltd. is a private medical device company that has developed a groundbreaking, advanced wound care product based on patented technology to reproduce the natural process of the body to heal wounds. Founded in 2010 by Dr. Igal Kushnir, MD and Alon Kushnir, the company is based in Israel and focused on developing effective solutions that improve outcomes for patients. RedDress management boasts vast experience in bringing breakthrough medical ideas to successful commercialization in the Biotechnology and Health Care industries. Their latest achievement includes a $26.00M Series D investment on 24 May 2023, led by HCS Capital Partners, Athos Therapeutics, and Ragnar. With their innovative approach to addressing unmet medical needs, RedDress is well-positioned for continued success.

Business keywords: medical device company, wound care, advanced technology, patented technology, Israel, biomedical innovation, commercialization, wound healing, medical breakthrough, patient outcomes, biomedical research, medical innovation, healthcare solutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $26.00M 3
HCS Capital, Athos Therapeutics +1
24 May 2023
Angel Round Undisclosed 1
Boston Harbor Angels
01 Sep 2010

RedDress Ltd. Alternatives & Competitors

View All Alternatives
RedDress Ltd. vs
Telesair, Inc
Telesair, Inc United States

Hospital Level Respiratory Care in the Home

Series A
31 employees
Health Care, Medical Devices
RedDress Ltd. vs

The first company to develop a novel peripheral neuropathy tissue healing product.

6 employees
Biotechnology, Health Care
RedDress Ltd. vs
DEBx Medical
DEBx Medical The Netherlands

Innovating the future of wound care

Private Equity
11 employees
Health Care, Medical Devices

FAQ About RedDress Ltd.

Healing is in Our Blood
RedDress Ltd. was founded in 2009.
RedDress Ltd. is headquartered in United States.
RedDress Ltd. operates in Biotechnology, Health Care and Medical Devices. Its work centres on medical device company, wound care, advanced technology and patented technology.
RedDress Ltd. has approximately 40 employees.
RedDress Ltd. has completed 2 funding rounds, raising a total of $26.00M. The latest funding stage is Series D.
Top alternatives and competitors to RedDress Ltd. include Telesair, Inc, Rapid Nexus Nanotech Wound Solutions, Inc., DEBx Medical, Reapplix, Piomic Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RedDress Ltd. and Telesair, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RedDress Ltd., https://bouncewatch.com/company/reddress-ltd, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout